Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
about
Bladder Preservation for Muscle Invasive Bladder CancerWhat are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients InvolvedNBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancerDouble-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeDNA Repair Pathway Alterations in Bladder Cancer.High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer.Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer.KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9.Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.Developing proteomic biomarkers for bladder cancer: towards clinical application.Radiogenomics and radiotherapy response modeling.Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumoursLandmarks in the treatment of muscle-invasive bladder cancer.No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy.Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply.Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.Genomic characterization of response to chemoradiation in urothelial bladder cancer.Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.Loss of expression of the tumour suppressor geneAIMP3predicts survival following radiotherapy in muscle-invasive bladder cancerDeveloping Predictive or Prognostic Biomarkers for Charged Particle RadiotherapyOverexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
P2860
Q26744750-1A47B65D-95D9-4498-B1C6-F54EB9706231Q26795518-F75F8C9E-2CCA-4A74-8F10-F6FF10D0FF84Q28070330-D92EF5FE-96A7-4162-8F8C-524A269020D1Q28251928-DF4C4F7A-805D-4E36-A91A-68FEFDABBB75Q28271788-C6273EE3-29BD-466D-82F7-9E3068CEAEB0Q33607945-2F328C7B-A234-4DF7-8A2F-7FD6D3342BABQ34184763-73E1DA8A-F720-4C11-8FC8-77C78A65AA36Q35869645-27C4FA0C-25C4-4444-81BA-C8F70876B105Q37452157-ECD3189F-A544-4AD0-BCF7-76982D00DCCCQ37671964-18FA9260-D175-475B-8A3D-2D63A396EF68Q38076093-BCCBBC29-97F6-441D-9275-606F25A3053CQ38511509-D084B6A3-E099-41E3-B632-5B17CF0308CBQ38665620-D2CC99AC-5E96-464C-BD81-D47BCD8CAE41Q39015929-48DF905F-003C-4884-9A4F-A4D487CF7FD1Q39413207-07C43E85-E779-4C91-BF9E-A3D4D6532CE2Q40161797-323225D6-A235-4164-BB1D-BE248C9D6152Q43081709-DCA90CCF-B3E8-4E69-BF06-1AE2F3F904BAQ43756593-6CB8CBFD-706E-4D6F-B781-C9DBFB27DCBCQ44338887-441D8DF0-9CA0-478C-8369-ECEBE5F2B4D2Q52743918-4DD92C07-B7DF-4BC5-83A1-EB715CF4EA9EQ56835133-4AC2F7F1-59DE-4CA1-9EEC-8D4AAF734091Q58569909-86FB5D38-F943-4717-A472-9A5DC2B715DCQ58768424-D36B5082-1C4E-430A-9508-001499571CB9
P2860
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Expression of TIP60 (tat-inter ...... lised invasive bladder cancer.
@en
Expression of TIP60
@nl
type
label
Expression of TIP60 (tat-inter ...... lised invasive bladder cancer.
@en
Expression of TIP60
@nl
prefLabel
Expression of TIP60 (tat-inter ...... lised invasive bladder cancer.
@en
Expression of TIP60
@nl
P2093
P2860
P50
P1433
P1476
Expression of TIP60 (tat-inter ...... lised invasive bladder cancer.
@en
P2093
Anne S Brems-Eskildsen
Arndt Hartmann
Benedicte P Ulhøi
Jens R Laurberg
Michael Borre
Michael Wittlinger
Niels Fristrup
Simone Bertz
Torben Orntoft
Troels Schepeler
P2860
P304
P356
10.1111/J.1464-410X.2012.11564.X
P433
P577
2012-10-09T00:00:00Z